Literature DB >> 9737692

Truncated c-Myb expression in the human leukemia cell line TK-6.

A Tomita1, T Watanabe, H Kosugi, H Ohashi, T Uchida, T Kinoshita, S Mizutani, T Hotta, T Murate, M Seto, H Saito.   

Abstract

The c-MYB proto-oncogene encodes a transcription factor which plays an important role in hematopoiesis. We detected truncated c-MYB mRNA (2.0 kb) and c-Myb protein (55 kDa) in the TK-6 cell line, which was established from a patient with chronic myelogenous leukemia in T cell blast crisis. Mutated c-MYB cDNA clone (WTK-1) was isolated from a TK-6 cell cDNA library and sequenced in its entirety. Compared with the wild-type human c-MYB sequence, the WTK-1 sequence diverged at the 3' ends of exons 9. A termination codon was present as the second codon downstream from the point of divergence and was followed by a previously unknown rearranged sequence. The conceptual protein encoded by WTK-1 (Myb(TK-6)) comprises 402 amino acids and lacks the negative regulatory domain of the normal c-Myb, reminiscent of the activated form of Myb protein. Luciferase reporter assay in NIH3T3 cells showed that the expression vector encoding Myb(TK-6) stimulated Myb-regulated mim-1 promoter more effectively than that encoding wild-type human c-Myb, suggesting that Myb(TK-6) is functional as a transcription factor, and thus as a potential transforming protein. Southern blot and mutant allele-specific polymerase chain reaction analyses showed that the same rearrangement of the c-MYB gene in TK-6 was present in late, but not in early, specimens obtained from the patient, indicating that this mutation had been acquired during disease progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737692     DOI: 10.1038/sj.leu.2401113

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  12 in total

1.  A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy.

Authors:  J A Iñiguez-Lluhí; D Pearce
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Stress-induced phosphorylation of Thr486 in c-Myb by p38 mitogen-activated protein kinases attenuates conjugation of SUMO-2/3.

Authors:  Juraj Bies; Marek Sramko; Linda Wolff
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

3.  Extensively hydrated but folded: a novel state of globular proteins stabilized at high pressure and low temperature.

Authors:  Sunilkumar Puthenpurackal Narayanan; Akihiro Maeno; Hiroshi Matsuo; Masayuki Oda; Hisayuki Morii; Kazuyuki Akasaka
Journal:  Biophys J       Date:  2012-01-18       Impact factor: 4.033

4.  Functional analysis of carboxy-terminal deletion mutants of c-Myb.

Authors:  D M Wang; J W Dubendorff; C H Woo; J S Lipsick
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.

Authors:  Yoshitsugu Mitani; Pulivarthi H Rao; P Andrew Futreal; Dianna B Roberts; Philip J Stephens; Yi-Jue Zhao; Li Zhang; Mutsumi Mitani; Randal S Weber; Scott M Lippman; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

6.  c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish.

Authors:  W Liu; M Wu; Z Huang; J Lian; J Chen; T Wang; A Y H Leung; Y Liao; Z Zhang; Q Liu; K Yen; S Lin; L I Zon; Z Wen; Y Zhang; W Zhang
Journal:  Leukemia       Date:  2016-06-14       Impact factor: 11.528

7.  Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis.

Authors:  Maria Rosa Lidonnici; Francesca Corradini; Todd Waldron; Timothy P Bender; Bruno Calabretta
Journal:  Blood       Date:  2008-01-28       Impact factor: 22.113

8.  Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer.

Authors:  Sofie Claerhout; Jae Yun Lim; Woonyoung Choi; Yun-Yong Park; Kyounghyun Kim; Sang-Bae Kim; Ju-Seog Lee; Gordon B Mills; Jae Yong Cho
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

9.  Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb.

Authors:  Liang Zhao; Evgeny A Glazov; Diwakar R Pattabiraman; Faisal Al-Owaidi; Ping Zhang; Matthew A Brown; Paul J Leo; Thomas J Gonda
Journal:  Nucleic Acids Res       Date:  2011-02-11       Impact factor: 16.971

10.  miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb.

Authors:  Junlan Feng; Yongzhi Yang; Peng Zhang; Feng Wang; Yanlei Ma; Huanlong Qin; Yu Wang
Journal:  J Cell Mol Med       Date:  2014-09-18       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.